Greenwood Capital Associates LLC Eli Lilly & CO Transaction History

Greenwood Capital Associates LLC

$755 Million
Q3 2024

A detailed history of Greenwood Capital Associates LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Greenwood Capital Associates LLC holds 10,912 shares of LLY stock, worth $8.38 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares

10,912

Previous 11,509 5.19%

Holding current value

$8.38 Million

Previous $10.4 Million 7.23%

% of portfolio

1.28%

Previous 1.4%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$772.14 - $960.02 $460,967 - $573,131	-597 Reduced 5.19%	10,912 $9.67 Million
Q2 2024 Aug 08, 2024	SELL	$724.87 - $909.04 $461,017 - $578,149	-636 Reduced 5.24%	11,509 $10.4 Million
Q1 2024 May 01, 2024	SELL	$592.2 - $792.28 $1.23 Million - $1.65 Million	-2,085 Reduced 14.65%	12,145 $9.45 Million
Q4 2023 Mar 05, 2024	SELL	$525.19 - $619.13 $209,550 - $247,032	-399 Reduced 2.73%	14,230 $8.29 Million
Q3 2023 Oct 18, 2023	SELL	$434.7 - $599.3 $985,030 - $1.36 Million	-2,266 Reduced 13.41%	14,629 $7.86 Million
Q2 2023 Aug 07, 2023	SELL	$350.74 - $468.98 $1.62 Million - $2.17 Million	-4,632 Reduced 21.52%	16,895 $7.92 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $732,776 - $860,610	2,359 Added 12.31%	21,527 $7.39 Million
Q4 2022 Jan 26, 2023	SELL	$321.55 - $374.67 $408,690 - $476,205	-1,271 Reduced 6.22%	19,168 $0
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $98,431 - $112,172	-332 Reduced 1.6%	20,439 $6.61 Million
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $5.77 Million - $6.78 Million	20,710 Added 33950.82%	20,771 $6.73 Million
Q1 2022 May 10, 2022	SELL	$234.69 - $291.66 $9.67 Million - $12 Million	-41,221 Reduced 99.85%	61 $17,000
Q4 2021 Feb 03, 2022	SELL	$224.85 - $279.04 $112,874 - $140,078	-502 Reduced 1.2%	41,282 $11.4 Million
Q3 2021 Oct 27, 2021	BUY	$221.6 - $272.71 $1.11 Million - $1.36 Million	4,991 Added 13.57%	41,784 $9.66 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $79,983 - $103,458	-443 Reduced 1.19%	36,793 $8.45 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $950,755 - $1.23 Million	-5,786 Reduced 13.45%	37,236 $6.96 Million
Q4 2020 Feb 09, 2021	SELL	$130.46 - $172.63 $121,066 - $160,200	-928 Reduced 2.11%	43,022 $7.26 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $773,357 - $894,528	5,289 Added 13.68%	43,950 $6.51 Million
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $1.27 Million - $1.53 Million	-9,291 Reduced 19.38%	38,661 $6.35 Million
Q1 2020 May 12, 2020	BUY	$119.05 - $147.35 $278,100 - $344,209	2,336 Added 5.12%	47,952 $6.65 Million
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $1.76 Million - $2.19 Million	16,507 Added 56.71%	45,616 $6 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $3.11 Million - $3.38 Million	29,109 New	29,109 $3.26 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.

Account

Greenwood Capital Associates LLC Eli Lilly & CO Transaction History